Clinical Trials Logo

Filter by:
NCT ID: NCT03586999 Active, not recruiting - Clinical trials for Peripheral T Cell Lymphoma

Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas

Start date: November 7, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This regimen aims to become the first line treatment for peripheral T cell lymphoma, using nivolumab with the standard of care chemotherapy.

NCT ID: NCT03586869 Active, not recruiting - Pancreatic Cancer Clinical Trials

QUILT-3.080: NANT Pancreatic Cancer Vaccine

Start date: July 28, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1b/2 study to evaluate the safety and efficacy of metronomic combination therapy in subjects with pancreatic cancer who have progressed on or after previous Standard of Care (SoC) chemotherapy.

NCT ID: NCT03586661 Active, not recruiting - Clinical trials for Recurrent Ovarian Carcinoma

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Start date: April 29, 2019
Phase: Phase 1
Study type: Interventional

This phase Ib trial studies the best dose and side effects of niraparib and copanlisib in treating patients with endometrial, ovarian, primary peritoneal, or fallopian tube cancer that has come back. Niraparib and copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT03586414 Active, not recruiting - Clinical trials for Diastolic Dysfunction

MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

In this pilot study, the investigators will determine whether supplementation with a mitochondrial-targeted antioxidant (Mitoquinone (MitoQ)) improves mitochondrial function, left ventricular diastolic and vascular function.

NCT ID: NCT03586362 Active, not recruiting - Pneumonia Clinical Trials

Vancomycin De-escalation Therapy in Patients With Pneumonia

Start date: February 8, 2018
Phase:
Study type: Observational

This is a non-inferiority study evaluating clinical improvement rate when using MRSA nasal swabs to guide discontinuation of vancomycin for empiric coverage for MRSA pneumonia.

NCT ID: NCT03586102 Active, not recruiting - Premature Infant Clinical Trials

Effect of Increased Enteral Protein on Body Composition of Preterm Infants

Start date: August 23, 2018
Phase: N/A
Study type: Interventional

The study hypothesis is that, in human milk-fed extremely preterm infants, higher protein intake compared to usual protein intake reduces percent body fat (%BF) at 3 months of age.

NCT ID: NCT03585114 Active, not recruiting - Clinical trials for Metastatic Prostate Cancer

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

Start date: December 11, 2018
Phase: Phase 2
Study type: Interventional

Primary Objective: - To determine whether changes in uptake of [18F]DCFPyL PET/CT scans at baseline and after 6 weeks of treatment for metastatic castrate resistant prostate cancer, correlates with radiographic progression free survival (rPFS) as defined by Prostate Cancer Working Group 3 (PCWG3) criteria. Secondary Objectives: - To determine whether changes in uptake of [18F]DCFPyL PET/CT scans correlate with overall survival (OS) - To determine whether baseline SUVmax correlate with rPFS - To compare number of lesions detected with standard imaging at baseline and at the time of progression

NCT ID: NCT03585010 Active, not recruiting - Clinical trials for Generalized Anxiety Disorder

Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

This study aims to investigate whether a parent-based treatment for childhood anxiety disorders engages child brain circuitry implicated in children's reliance on parents to reduce anxiety (R61), and whether change in child brain circuitry is associated with reduction in child anxiety (R33).

NCT ID: NCT03584854 Active, not recruiting - Clinical trials for Postpartum Hemorrhage

Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

Start date: March 1, 2019
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate in a randomized fashion the comparative efficacy of two second-line medications, methylergonovine and carboprost for treating atonic postpartum hemorrhage (PPH). The investigators hypothesize that administration of methylergonovine will produce superior uterine tone to carboprost in atonic PPH.

NCT ID: NCT03584776 Active, not recruiting - Spinal Fusion Clinical Trials

Virtual Reality for Post-operative Pain Management

Start date: January 30, 2019
Phase: N/A
Study type: Interventional

Use an RCT study design to measure pain experience, medication use, medical side effects, and length of hospital stay with and without availability of VR following spine fusion surgery